EnzGFM-Agent experimentally prioritizes activity-enhancing secreted alkaline phosphatase variants
EnzGFM-Agent scored all possible single amino-acid substitutions in secreted alkaline phosphatase (SEAP) and selected top candidates from EnzGFM-1.5B and ESM2-3B for testing in transfected Chinese hamster ovary cells. Among the five variants uniquely prioritized by EnzGFM, all five had significantly higher measured activity than wild type in the reported assay; three exceeded 1.5-fold, and A46I reached 6.52-fold. This is an experimentally measured enzyme-engineering result for the tested SEAP variants.
Technology: EnzGFM-Agent with EnzGFM-1.5B and ESM2-3B
Family ESM / ESMFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: EnzGFM-Agent scored all possible single amino-acid substitutions in secreted alkaline phosphatase (SEAP) and selected top candidates from EnzGFM-1.5B and ESM2-3B for testing in transfected Chinese hamster ovary cells.
- Still unknown: The evidence is limited to single substitutions in one SEAP reporter protein tested after transfection in CHO-S cells, with three independent biological replicates; it does not establish improved activity for other enzymes, industrial process performance, or a naturally occurring enzyme function. The five EnzGFM-specific variants all differed significantly from wild type, but the study also evaluated ESM2-ranked variants and five variants shared by both models. This is a paper-specific experimental validation, not independent replication.
- AI role: The workflow scored every possible SEAP single-point substitution, ranked candidates using EnzGFM-1.5B and ESM2-3B, and selected 15 unique variants for experimental validation. The distinct EnzGFM-prioritized group comprised five variants; the paper reports significantly increased SEAP activity for all five, with A46I at 6.52-fold wild type.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13494029/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.